This page in Swedish

Research projects

The effect of probiotic supplementation on antibody response against SARS-CoV-2 in healthy adults

About this project

Project information

Project status



Richard Forsgård

Research subject

Research environments

TThe global outbreak of the coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents a serious threat to public health. Probiotics are living microorganisms which confer health benefits to the host, and they have shown positive effects on antibody responses following certain vaccinations against other viruses. One of these probiotics, Limosilactobacillus reuteri, has shown to be able to decrease the number of sick leave days during influenza season as well as increase the production of certain antibodies.

The aim of this project is to examine the effect of daily probiotic supplementation on antibody response against SARS-CoV-2

Forsgård RA, Rode J, Lobenius-Palmér K, Kamm A, Patil S, Tacken MGJ, Lentjes MAH, Axelsson J, Grompone G, Montgomery S, Brummer RJ. Limosilactobacillus reuteri DSM 17938 supplementation and SARS-CoV-2 specific antibody response in healthy adults: a randomized, triple-blinded, placebo-controlled trial. Gut Microbes. 2023 Jan-Dec;15(1):2229938. doi: 10.1080/19490976.2023.2229938. PMID: 37401761; PMCID: PMC10321188

Research groups

Research funding bodies

  • Biogaia AB
  • Örebro University